V

Vaxxel

9 employees

Vaxxel is an Innovative viral live-attenuated platform for intranasal vaccine candidates preventing against pneumovirus infections

Basic info

Industry

pharmaceutical manufacturing

Sectors

vaccin
biotechnologies
recherche-développement
santé
Pharmaceutical

Date founded

2019

Funding rounds raised

Total raised

$1.3M

from 1 investors over 1 rounds

V

Vaxxel raised $1.3M on March 18, 2022

Investors: Angels Santé

FAQ